Xiidra
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0078-0911 -
Package NDC
0078-0911-12 -
Package NDC
0078-0911-94 -
Application number
NDA208073 -
SPL ID
3cabbaea-c2bf-971c-e063-6394a90a4931 -
SPL set ID
8589d376-ac10-4ddb-9c53-2e0c8d5675c4 -
UNII
038E5L962W -
RxCUI
1801835 -
RxCUI
1801840
What the source publishes
- Labeler
- Novartis Pharmaceuticals Corporation
- Active ingredients
- Lifitegrast
- Form
- SOLUTION/ DROPS
- Routes
- OPHTHALMIC
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Xiidra",
"splId": "3cabbaea-c2bf-971c-e063-6394a90a4931",
"labels": [
{
"setId": "8589d376-ac10-4ddb-9c53-2e0c8d5675c4",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8589d376-ac10-4ddb-9c53-2e0c8d5675c4",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8589d376-ac10-4ddb-9c53-2e0c8d5675c4"
}
],
"routes": [
"OPHTHALMIC"
],
"labeler": "Novartis Pharmaceuticals Corporation",
"finished": true,
"packaging": [
{
"sample": false,
"description": "12 POUCH in 1 CARTON (0078-0911-12) / 5 AMPULE in 1 POUCH (0078-0911-05) / .2 mL in 1 AMPULE",
"package_ndc": "0078-0911-12",
"identifierStatus": "well-formed",
"marketing_end_date": "20270601",
"marketing_start_date": "20200604"
},
{
"sample": true,
"description": "4 POUCH in 1 CARTON (0078-0911-94) / 5 AMPULE in 1 POUCH (0078-0911-95) / .2 mL in 1 AMPULE",
"package_ndc": "0078-0911-94",
"identifierStatus": "well-formed",
"marketing_end_date": "20270201",
"marketing_start_date": "20200604"
}
],
"productId": "0078-0911_3cabbaea-c2bf-971c-e063-6394a90a4931",
"useDomain": "unknown",
"dosageForm": "SOLUTION/ DROPS",
"productNdc": "0078-0911",
"deaSchedule": null,
"genericName": "Lifitegrast",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LIFITEGRAST",
"strength": "50 mg/mL"
}
],
"applicationNumber": "NDA208073",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20160711",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000192701",
"N0000192700"
],
"unii": [
"038E5L962W"
],
"rxcui": [
"1801835",
"1801840"
],
"spl_set_id": [
"8589d376-ac10-4ddb-9c53-2e0c8d5675c4"
],
"pharm_class_epc": [
"Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]"
],
"pharm_class_moa": [
"Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]"
],
"manufacturer_name": [
"Novartis Pharmaceuticals Corporation"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0078-0911_3cabbaea-c2bf-971c-e063-6394a90a4931"